Ask AI
Bill115th CongressFiled May 4, 2017Health
S. 1049

Opioid Addiction Risk Transparency Act

Bill journey · stage 2 of 5

Under committee review

Filed
Comm.
Floor
Both
Law

What it doesSummary introduced in senate (May 4, 2017)

Opioid Addiction Risk Transparency Act

This bill amends the Federal Food, Drug, and Cosmetic Act to authorize the Food and Drug Administration to require a communication plan that is part of a medication's risk evaluation and mitigation strategy to include informing health care providers about the meaning of terms related to properties of the medication described in the labeling.

What just happenedMay 4, 2017

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Who’s behind it

Sen. Hassan, Margaret Wood [D-NH](D-NH)Sponsor
1 cosponsor1 R
Read on Congress.gov
1cosponsors1committees2actions1related bills3subjects
  1. May 4, 2017IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Health, Education, Labor, and Pensions Committee
  2. May 4, 2017IntroReferral10000

    Introduced in Senate

Opioid Addiction Risk Transparency Act — Informed